This application relates generally to methods and devices for repairing an intervertebral disc. More specifically, the application relates to a percutaneously deployed implantable disc replacement and methods for manufacturing such a disc replacement/prosthesis.
A common medical issue is back pain due to spinal disc injuries caused by trauma, the aging process or other disorders. One method of treatment that has been proposed is to remove the existing nucleus pulposus and replace it with a nuclear prosthesis formed in situ using open surgery or minimally invasive surgical techniques. One proposed method comprises the steps of (i) providing a mold, such as a balloon, to contain a flowable curable material that can cure in situ within the disc space, (ii) providing a conduit to connect the mold cavity to a source of flowable curable material, (iii) delivering the flowable curable material into the mold to fill the cavity, and (iv) permitting the curable material to cure.
The existing techniques for forming a nuclear prosthesis in situ have not achieved convincing clinical acceptance or commercial success. One problem identified by the present inventors is the substantial difference in the modulus of elasticity between the vertebral bony elements, including the vertebral end plates, and the annulus fibrosus on the one hand, and the implanted elements on the other. The high modulus of elasticity of the implanted material is disadvantageous since it does not dampen impacts or sudden increases in intradiscal pressure during extreme bending or torsion, especially during high loading peaks. The large difference in the modulus of elasticity between implanted disc materials and adjacent tissues can also lead to softening of the vertebral end plates and adjacent bone (spongeosus), resulting in subsidence of the nuclear implant. Migration and expulsion of the implant can also occur.
Therefore, there is a need for an improved nuclear implant.
An object of exemplary embodiments of the present invention is to provide a method of manufacturing an elastomeric enclosure for a multi-chamber nuclear implant that can selectively and controllably be inflated and deflated with materials that, together, provide physical and mechanical properties similar to those of a normal disc, and which can be tailored to individual patient parameters.
Another object of exemplary embodiments of the present invention is to provide a method of fabricating a nuclear implant that can be deployed percutaneously in a disc cavity and inflated to conform to the shape and size of the disc cavity.
A further object of exemplary embodiments of the present invention is to provide a nuclear implant which reinforces the annulus fibrosus if it is torn.
According to an exemplary embodiment, an implantable prosthetic device comprises an inner inflatable enclosure having a first opening and an outer inflatable enclosure having a first opening. The outer inflatable enclosure encapsulates the inner inflatable enclosure. A valve assembly sealingly couples the first opening of the outer inflatable enclosure and the first opening of the inner inflatable enclosure, and the valve assembly is configured to allow independent inflation of the outer and inner inflatable enclosures. An annular reinforcement band is provided around the periphery of the outer inflatable enclosure. When implanted, the inner chamber is filled with a compressible material and the outer inflatable enclosure is filled with an in situ curable material, such as silicone. This structure allows for vertical and horizontal load stresses placed on the implant to be redirected inward, centrally toward the inner compressible enclosure instead of outward.
The inner and outer inflatable enclosures may comprise a seamless, unitary piece of material. The inner inflatable enclosure may have a second opening generally opposite of the first opening, the outer inflatable enclosure may have a second opening generally opposite of the first opening, and a plug may sealingly couple the second opening of the inner inflatable enclosure and the second opening of the outer inflatable enclosure. The plug may be coupled to a neck portion of the second opening of the outer inflatable enclosure. The plug and the neck portion of the second opening of the outer inflatable enclosure may be coupled to a neck portion of the second opening of the inner inflatable enclosure.
The annular reinforcement band may be placed into the second opening of the inner inflatable enclosure and then the distal plug may be inserted into the second opening to couple the reinforcement band to the balloon. The reinforcement band may be coupled to the inflatable enclosure at only one location, such as at the plug. A fastener may be provided to fasten the reinforcement band to the plug. The reinforcement band may include a shape memory material. The annular reinforcement band may comprise a tubular braid enclosing the shape memory material.
The valve assembly may comprise a valve core coupling the first openings of the outer and inner inflatable enclosures. The valve core has an opening from an interior of the valve core to an exterior of the valve core. A valve membrane partially envelops the valve core and has an opening into the outer inflatable enclosure. The opening in the valve membrane and the valve core are separated from one another to allow material to flow into the outer inflatable enclosure, while preventing backflow. The valve core may further comprise a resealable, puncturable membrane to provide access to the inner inflatable enclosure.
The valve membrane and the valve core may be integrally molded, or the valve core may be bonded to the valve membrane with an adhesive.
The inner and outer inflatable enclosures may comprise an elastomer, such as silicone rubber.
In some embodiments, a curable material may be provided to inflate the outer inflatable enclosure, and a compressible material such as gas may be provided to inflate the inner inflatable enclosure to allow the cured material to deform. The cured material may substantially surround the inner inflatable enclosure. In other embodiments, an incompressible material (e.g., a liquid) is provided to inflate the inner inflatable enclosure and then the curable material is injected into the outer inflatable enclosure. The incompressible material is then removed from the inner inflatable enclosure and replaced with a compressible material (e.g., a gas). In certain embodiments, the curable material further polymerizes with the inner and outer inflatable enclosures to form a solid, unitary member.
In accordance with an exemplary embodiment, a valve assembly for inflating an implantable prosthetic device comprising an inner inflatable enclosure connected to an outer inflatable enclosure comprises an elastomeric membrane forming a passageway from an interior of the inner inflatable enclosure to an exterior of the outer inflatable enclosure and a valve core disposed in the passageway so that the elastomeric membrane surrounds the valve core. The elastomeric membrane has an opening into an interior of the outer inflatable enclosure, and the elastomeric membrane surrounds the valve core. The valve core comprises a conduit extending from a first end to a second end, and a resealable, puncturable membrane at the second end of the valve core conduit for providing resealable access to the inner inflatable enclosure. An opening in the conduit extends from an interior of the conduit to an exterior of the conduit, and the opening in the valve core is offset from the opening in the elastomeric membrane to form a one way valve allowing material introduced into the interior of the conduit to pass into the interior of the outer inflatable enclosure while preventing backflow.
In accordance with an exemplary embodiment, a method of implanting a prosthetic device into an intervertebral space having a nucleus pulposus surrounded by an annulus fibrosus comprises penetrating the annulus fibrosus, removing the nucleus pulposus, and implanting an implantable prosthetic device, wherein the implantable prosthetic device comprises an inner inflatable enclosure having a first opening and an outer inflatable enclosure having a first opening. The outer inflatable enclosure encapsulates the inner inflatable enclosure. A valve assembly sealingly couples the first opening of the outer inflatable enclosure and the first opening of the inner inflatable enclosure, and the valve assembly is configured to allow independent inflation of the outer and inner inflatable enclosures. A reinforcement band is provided around the periphery of the outer inflatable enclosure.
In some embodiments, the method may further comprise inflating the inner inflatable enclosure using a compressible material, and the compressible material may comprise a gas. The method may further comprise inflating the outer inflatable enclosure using a curable material, and the curable material may be silicone rubber. In other embodiments, the method may further comprise inflating the inner inflatable enclosure using an incompressible material, and the incompressible material may comprise a liquid. The method may further comprise inflating the outer inflatable enclosure using a curable material, allowing the curable material to cure, and then replacing the incompressible material in the inner inflatable enclosure with a compressible material.
In accordance with an exemplary embodiment, a method of producing an implantable prosthetic device comprises (i) injection molding a prosthesis blank comprising an outer membrane section with a proximal end and a distal end, an inner membrane section with a proximal end and a distal end, a valve section disposed between the proximal end of the outer membrane section and the proximal end of the inner membrane section, a distal plug inner section at the distal end of the inner membrane section, and a distal plug outer section at the distal end of the outer membrane section; and (ii) partially inverting the prosthesis blank so that the outer membrane section encloses the inner membrane section to form an outer balloon surrounding an inner balloon formed by the inner membrane.
In accordance with an exemplary embodiment, a method of producing an implantable prosthetic device comprises (i) providing a mandrel with a profiled outer surface configured to form a prosthesis blank comprising an outer membrane section with a proximal end and a distal end, an inner membrane section with a proximal end and a distal end, a valve section disposed between the proximal end of the outer membrane section and the proximal end of the inner membrane section, a distal plug inner section at the distal end of the inner membrane section, and a distal plug outer section at the distal end of the outer membrane section; (ii) coating the mandrel with a material to form the prosthesis blank; (iii) stripping the prosthesis blank from the mandrel; and (iv) partially inverting the prosthesis blank so that the outer membrane section encloses the inner membrane section to form an outer balloon surrounding an inner balloon formed by the inner membrane.
The mandrel may comprise a unitary body, and the valve section of the mandrel may comprise a valve core that is integrally molded with the prosthesis blank. The mandrel may comprise two separable pieces coupled to the valve core, and the step of stripping the prosthesis blank from the mandrel may comprise separating the mandrel pieces from the valve core and removing the separable pieces from the prosthesis blank.
The valve core may be glued into the valve section.
The distal plug may be inserted into the distal plug outer section to seal the distal plug outer section, and the distal plug and distal plug outer section may be inserted into the distal plug inner section.
A reinforcing band may be joined to the distal plug, and the reinforcing band, distal plug, and distal plug outer section may be inserted into the distal plug inner section. The reinforcing band may be joined to the distal plug with a fastener.
The mandrel may be coated by dipping it into a polymer liquid, which may comprise a silicone dispersion, and dried.
The elastomeric membrane may be stripped from the mandrel by melting the mandrel, or the prosthesis blank may be removed from the mandrel by stretching it over the mandrel. A reinforcing band may be applied around the periphery of the outer balloon.
In accordance with an exemplary embodiment, a mandrel for producing an implantable prosthetic device comprises a first balloon mandrel with a profiled outer surface configured in the shape of a first balloon; a second balloon mandrel with a profiled outer surface configured in the shape of a second balloon; and a valve core disposed between the first and second balloon mandrels. The outer surface of the first balloon mandrel may further comprises a distal opening section, and the outer surface of the second balloon mandrel may further comprise a distal opening section. The outer surfaces of the balloon mandrels may be curved. The outer surfaces of each of the balloon mandrels may comprise a central section with a generally uniform diameter.
In accordance with an exemplary embodiment, a mandrel for producing an implantable prosthetic device comprises a unitary body with a profiled outer surface. The profiled outer surface has an outer membrane section configured to form an annular balloon with a proximal end and a distal end; an inner membrane section configured to form a nuclear balloon with a proximal end and a distal end; a valve section configured to receive a valve assembly disposed between the proximal end of the outer membrane section and the proximal end of the inner membrane section; a distal plug outer section configured to receive a distal plug at the distal end of the outer membrane section; and a distal plug inner section configured to receive an assembly of the distal plug and distal plug outer section at the distal end of the inner membrane section.
The term “coupled” is defined as connected, although not necessarily directly. The terms “a” and “an” are defined as one or more unless this disclosure explicitly requires otherwise. The terms “substantially,” “approximately,” and “about” are defined as largely but not necessarily wholly what is specified (and includes what is specified; e.g., substantially 90 degrees includes 90 degrees and substantially parallel includes parallel), as understood by a person of ordinary skill in the art. In any disclosed embodiment, the terms “substantially,” “approximately,” and “about” may be substituted with “within [a percentage] of” what is specified, where the percentage includes 0.1, 1, 5, and 10 percent.
The terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have, such as “has” and “having”), “include” (and any form of include, such as “includes” and “including”) and “contain” (and any form of contain, such as “contains” and “containing”) are open-ended linking verbs. As a result, a system, or a component of a system, that “comprises,” “has,” “includes” or “contains” one or more elements or features possesses those one or more elements or features, but is not limited to possessing only those elements or features. Likewise, a method that “comprises,” “has,” “includes” or “contains” one or more steps possesses those one or more steps, but is not limited to possessing only those one or more steps. Additionally, terms such as “first” and “second” are used only to differentiate structures or features, and not to limit the different structures or features to a particular order.
A device, system, or component of either that is configured in a certain way is configured in at least that way, but it can also be configured in other ways than those specifically described.
Any embodiment of any of the systems and methods can consist of or consist essentially of—rather than comprise/include/contain/have—any of the described elements, features, and/or steps. Thus, in any of the claims, the term “consisting of” or “consisting essentially of” can be substituted for any of the open-ended linking verbs recited above, in order to change the scope of a given claim from what it would otherwise be using the open-ended linking verb.
The feature or features of one embodiment may be applied to other embodiments, even though not described or illustrated, unless expressly prohibited by this disclosure or the nature of the embodiments.
Details associated with the embodiments described above and others are presented below.
In the following detailed description, reference is made to the accompanying drawings, in which are shown exemplary but non-limiting and non-exhaustive embodiments of the invention. These embodiments are described in sufficient detail to enable those having skill in the art to practice the invention, and it is understood that other embodiments may be used, and other changes may be made, without departing from the spirit or scope of the invention. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the invention is defined only by the appended claims. In the accompanying drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.
Description of Implant
Referring to
An annular reinforcing band 110 may be disposed around the perimeter of the lateral edges of implant 100 to minimize or prevent over-stretching of the elastomeric membrane or over inflation of outer and inner balloons 102, 104 circumferentially. Annular reinforcement band 110 encourages vertical expansion to widen the disc space. The vertebral superior and inferior end plates constrain the expansion of the implant 100.
The size of implant 100 is selected so that it can be percutaneously inserted into a denucleated intervertebral disc space while deflated and then inflated to fill the denucleated cavity. In one embodiment, the exterior of inflated implant 100 is approximately 30 mm in length, 20 mm in width, and 10 mm in height, and the exterior of inner inflatable enclosure 104 is approximately 9 mm long, 6 mm wide, and 6 mm thick.
Annular reinforcing band 110 may be a biocompatible textile material. In one embodiment, annular reinforcing band 110 comprises a tubular, woven textile material. Annular reinforcing band 110 may also include an expandable member to provide additional support. The expandable member may be formed of a shape memory material, such as nitinol. U.S. Pat. No. 8,636,803, entitled Percutaneous Implantable Nuclear Implant, discloses one suitable construction of annular reinforcing band 110, and is hereby incorporated by reference in its entirety for all purposes.
Outer inflatable enclosure 102 has a first opening 118 and a second opening 120. Inner inflatable enclosure 104 has a first opening 136 and a second opening 138. A proximal plug, or valve core, 112 connects first opening 118 and first opening 136. A valve membrane 122 surrounds proximal plug 112 and cooperates with proximal plug 112 to form an inflation valve 124. Inflation valve 124 is a one-way valve which allows material to be introduced into annular chamber 106. Preferably, valve membrane 122 is formed integrally with outer and inner inflatable enclosures 102, 104, as will be described in further detail below. As seen most clearly in
A distal plug 146 is disposed in a neck portion 148 extending from second opening 138 of the inner inflatable enclosure 104. The distal plug 148 is bonded to the neck portion 148 to form a fluid tight seal. The distal plug 146 and neck portion 148 assembly is disposed within a neck portion 150 extending from second opening 120 of outer inflatable enclosure 102. Annular reinforcing band 110 may be trapped between the distal plug 146 and neck portion 148 assembly and the neck portion 150 to serve as an anchor for reinforcing band 110. Alternatively, a fastener 152 may be used to anchor annular reinforcing band 110 to distal plug 146, as seen most clearly in
Method of Manufacturing the Implant
Referring to
After curing or drying, implant blank 154 is stripped from mandrel 156. This may be accomplished by stretching implant blank 154 over mandrel 156. If mandrel 156 is composed of separable pieces, it may be disassembled prior to stripping. In one embodiment, mandrel 156 may be formed of a meltable or dissolvable material and melted or dissolved to strip implant blank 154 from mandrel 156. Opening 134 through valve membrane 122 is formed in implant blank 154.
Referring to
In another embodiment, implant blank 154 is formed by injection molding over a mandrel using conventional techniques. That is, the mandrel is placed into an injection mold having a cavity corresponding to the outer shape of the implant blank, and a curable material is injected into the mold under pressure. The curable material is allowed to cure, thereby forming implant blank 154 over the mandrel. The mandrel and implant blank 154 are then removed from the injection mold. Once implant blank 154 is formed, the remaining assembly steps are as described in the prior paragraph.
Method of Deploying an Implant
Referring to
Referring to
After the nucleus pulposus has been removed, deployment cannula 180 with preloaded implant 100 is placed into the empty disc cavity 182. The implant 100 is deployed by pushing it out of the deployment cannula and into the empty disc cavity, as shown in
In one embodiment, nuclear chamber 108 is first inflated with a compressible fluid 194, such as a gas. This may be performed using a needle (not shown) which is delivered through the inflation stylus 116 and pushed through the puncturable, resealable membrane 144. The compressible fluid is deployed into the nuclear chamber 108 to inflate the inner inflatable enclosure 104. The pressure of the nuclear chamber 108 is selected so that it provides a buffer zone for inward deformation of the cured elastomer 186 during weight bearing and spine movement. Once nuclear chamber 108 is inflated to the desired pressure, the needle is withdrawn from nuclear chamber 108. In another embodiment, instead of using a removable needle, inflation stylus 116 may have a septum extending through the stylus to divide the stylus into two lumens. One lumen extends through resealable, puncturable membrane 144 into nuclear chamber 108, while the other lumen delivers an in situ curable material to implant valve 124 and annular chamber 106.
Inflation stylus 116 is used to deliver an in situ curable material to annular chamber 106 through the one way implant valve 124 (
After the curable material is allowed to cured, the implant 100 comprises an annular ring of a cured elastomer 186 surrounding nuclear chamber 108 which is filled with a compressible material 194. This structure allows for vertical and horizontal load stresses placed on the intervertebral disc space to be redirected inward, centrally toward nuclear chamber 108 (see direction arrows of
In another embodiment, nuclear chamber 108 is first inflated with an incompressible fluid, such as a liquid. This may be performed using a needle or an inflation stylus, as described above. Once nuclear chamber 194 is inflated, inflation stylus 116 is used to deliver an in situ curable material to annular chamber 106 through the one way implant valve 124. After the curable material is allowed to cured, the incompressible fluid is removed from nuclear chamber 108 and replaced with compressible material 194. This may be accomplished with a needle using implant valve 124.
The above specification and examples provide a complete description of the structure and use of exemplary embodiments. Although certain embodiments have been described above with a certain degree of particularity, or with reference to one or more individual embodiments, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the scope of this invention. As such, the various illustrative embodiments of the present devices are not intended to be limited to the particular forms disclosed. Rather, they include all modifications and alternatives falling within the scope of the claims, and embodiments other than the one shown may include some or all of the features of the depicted embodiment. For example, components may be combined as a unitary structure, and/or connections may be substituted (e.g., threads may be substituted with press-fittings or welds). Further, where appropriate, aspects of any of the examples described above may be combined with aspects of any of the other examples described to form further examples having comparable or different properties and addressing the same or different problems. Similarly, it will be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments.
The claims are not intended to include, and should not be interpreted to include, means-plus- or step-plus-function limitations, unless such a limitation is explicitly recited in a given claim using the phrase(s) “means for” or “step for,” respectively.
This application is a divisional of U.S. patent application Ser. No. 14/932,242 filed Nov. 4, 2015, which claims the benefit of priority of U.S. Provisional Patent Application No. 62/074,925, filed Nov. 4, 2014. The entire contents of each of the above-referenced applications are specifically incorporated herein by reference without disclaimer.
Number | Name | Date | Kind |
---|---|---|---|
3875595 | Froning | Apr 1975 | A |
4187390 | Gore | Feb 1980 | A |
4478898 | Kato | Oct 1984 | A |
4517979 | Pecenka | May 1985 | A |
4619641 | Schanzer | Oct 1986 | A |
4743480 | Campbell et al. | May 1988 | A |
5123926 | Pisharodi | Jun 1992 | A |
5152782 | Kowligi et al. | Oct 1992 | A |
5181921 | Makita et al. | Jan 1993 | A |
5192310 | Herweck et al. | Mar 1993 | A |
5192326 | Bao et al. | Mar 1993 | A |
5437661 | Rieser | Aug 1995 | A |
5439464 | Shapiro | Aug 1995 | A |
5466509 | Kowligi et al. | Nov 1995 | A |
5571189 | Kuslich | Nov 1996 | A |
5628786 | Banas et al. | May 1997 | A |
5645597 | Krapiva | Jul 1997 | A |
5674295 | Ray et al. | Oct 1997 | A |
5702449 | McKay | Dec 1997 | A |
5752969 | Cunci et al. | May 1998 | A |
5827327 | McHaney et al. | Oct 1998 | A |
5860425 | Benderev et al. | Jan 1999 | A |
5865845 | Thalgott | Feb 1999 | A |
5879366 | Shaw et al. | Mar 1999 | A |
5888220 | Felt | Mar 1999 | A |
5888226 | Rogozinski | Mar 1999 | A |
5890268 | Mullen et al. | Apr 1999 | A |
5910277 | Ishino et al. | Jun 1999 | A |
5928284 | Mehdizadeh | Jul 1999 | A |
5935147 | Kensey et al. | Aug 1999 | A |
5954767 | Pajotin et al. | Sep 1999 | A |
5972022 | Huxel | Oct 1999 | A |
5976174 | Ruiz | Nov 1999 | A |
5981826 | Ku et al. | Nov 1999 | A |
5990378 | Ellis | Nov 1999 | A |
6001125 | Golds et al. | Dec 1999 | A |
6001130 | Bryan et al. | Dec 1999 | A |
6007570 | Sharkey et al. | Dec 1999 | A |
6007575 | Samuels | Dec 1999 | A |
6019793 | Perren et al. | Feb 2000 | A |
6036724 | Lentz et al. | Mar 2000 | A |
6079868 | Rydell | Jun 2000 | A |
6126682 | Sharkey et al. | Oct 2000 | A |
6127597 | Beyar | Oct 2000 | A |
6140452 | Felt et al. | Oct 2000 | A |
6146419 | Eaton | Nov 2000 | A |
6180848 | Flament et al. | Jan 2001 | B1 |
6183518 | Ross et al. | Feb 2001 | B1 |
6206921 | Guagliano et al. | Mar 2001 | B1 |
6224630 | Bao et al. | May 2001 | B1 |
6248131 | Felt et al. | Jun 2001 | B1 |
6264695 | Stoy | Jul 2001 | B1 |
6332894 | Stalcup et al. | Dec 2001 | B1 |
6344054 | Parodi | Feb 2002 | B1 |
6361637 | Martin et al. | Mar 2002 | B2 |
6375682 | Fleischmann et al. | Apr 2002 | B1 |
6390992 | Morris et al. | May 2002 | B1 |
6395032 | Gauchet | May 2002 | B1 |
6398803 | Layne et al. | Jun 2002 | B1 |
6402750 | Atkinson et al. | Jun 2002 | B1 |
6419704 | Ferree | Jul 2002 | B1 |
6428576 | Haldimann | Aug 2002 | B1 |
6436143 | Ross et al. | Aug 2002 | B1 |
6443988 | Felt et al. | Sep 2002 | B2 |
6482234 | Weber et al. | Nov 2002 | B1 |
6527804 | Gauchet et al. | Mar 2003 | B1 |
6533818 | Weber et al. | Mar 2003 | B1 |
6582466 | Gauchet | Jun 2003 | B1 |
6596008 | Kambin | Jul 2003 | B1 |
6632235 | Weikel et al. | Oct 2003 | B2 |
6645248 | Casutt | Nov 2003 | B2 |
6673103 | Golds et al. | Jan 2004 | B1 |
6689125 | Keith et al. | Feb 2004 | B1 |
6712853 | Kuslich | Mar 2004 | B2 |
6733532 | Gauchet et al. | May 2004 | B1 |
6733533 | Lozier | May 2004 | B1 |
6780497 | Walter | Aug 2004 | B1 |
6852095 | Ray | Feb 2005 | B1 |
6852223 | Huang et al. | Feb 2005 | B2 |
6866681 | Laboureau et al. | Mar 2005 | B2 |
6893465 | Huang | May 2005 | B2 |
6893466 | Trieu | May 2005 | B2 |
6932843 | Smith et al. | Aug 2005 | B2 |
6936070 | Muhanna | Aug 2005 | B1 |
6958077 | Suddaby | Oct 2005 | B2 |
6969404 | Ferree | Nov 2005 | B2 |
6969405 | Suddaby | Nov 2005 | B2 |
6984246 | Huang | Jan 2006 | B2 |
7001431 | Bao et al. | Feb 2006 | B2 |
7004971 | Serhan et al. | Feb 2006 | B2 |
7008427 | Sevrain | Mar 2006 | B2 |
7056345 | Kuslich | Jun 2006 | B2 |
7077865 | Bao et al. | Jul 2006 | B2 |
7133001 | Mrstik et al. | Nov 2006 | B2 |
7156861 | Scribner et al. | Jan 2007 | B2 |
7156877 | Lotz et al. | Jan 2007 | B2 |
7182783 | Trieu | Feb 2007 | B2 |
7201751 | Zucherman et al. | Apr 2007 | B2 |
7201776 | Ferree et al. | Apr 2007 | B2 |
7204851 | Trieu et al. | Apr 2007 | B2 |
7220282 | Kuslich | May 2007 | B2 |
7267687 | McGuckin et al. | Sep 2007 | B2 |
7273497 | Ferree | Sep 2007 | B2 |
7297158 | Jensen | Nov 2007 | B2 |
7309359 | Trieu et al. | Dec 2007 | B2 |
7556650 | Collins et al. | Jul 2009 | B2 |
7563284 | Coppes et al. | Jul 2009 | B2 |
7618461 | Trieu | Nov 2009 | B2 |
7632291 | Stephens et al. | Dec 2009 | B2 |
7632294 | Milbodker et al. | Dec 2009 | B2 |
7641691 | Lotz et al. | Jan 2010 | B2 |
7645301 | Hudgins et al. | Jan 2010 | B2 |
7713301 | Bao et al. | May 2010 | B2 |
7722612 | Sala et al. | May 2010 | B2 |
7731753 | Reo et al. | Jun 2010 | B2 |
7766965 | Bao et al. | Aug 2010 | B2 |
7789913 | Collins et al. | Sep 2010 | B2 |
7799079 | Hestad et al. | Sep 2010 | B2 |
7837733 | Collins et al. | Nov 2010 | B2 |
7842055 | Pintor et al. | Nov 2010 | B2 |
7896920 | Yuksel et al. | Mar 2011 | B2 |
7931689 | Hochschuler et al. | Apr 2011 | B2 |
7947079 | Helm et al. | May 2011 | B2 |
7972351 | Trinidad | Jul 2011 | B2 |
7993351 | Worley et al. | Aug 2011 | B2 |
7993404 | Trieu | Aug 2011 | B2 |
7998210 | Edie et al. | Aug 2011 | B2 |
8012210 | Lin et al. | Sep 2011 | B2 |
8012211 | Kuslich | Sep 2011 | B2 |
8043381 | Hestad et al. | Oct 2011 | B2 |
8066758 | Bogert et al. | Nov 2011 | B2 |
8083800 | Edie | Dec 2011 | B2 |
8092536 | Ahrens et al. | Jan 2012 | B2 |
8100978 | Bass | Jan 2012 | B2 |
8123808 | Dewey et al. | Feb 2012 | B2 |
8133250 | Parsonage et al. | Mar 2012 | B2 |
8142456 | Rosqueta et al. | Mar 2012 | B2 |
8142489 | Doran et al. | Mar 2012 | B2 |
8236057 | Wirtel, III et al. | Aug 2012 | B2 |
8246682 | Slivka et al. | Aug 2012 | B2 |
8287595 | Vresilovic et al. | Oct 2012 | B2 |
8292961 | Osman | Oct 2012 | B2 |
8317864 | Kim | Oct 2012 | B2 |
8337556 | Shaolian et al. | Dec 2012 | B2 |
8337557 | Collins et al. | Dec 2012 | B2 |
8349013 | Zucherman et al. | Jan 2013 | B2 |
8377131 | Lin | Feb 2013 | B2 |
8377136 | Simonton | Feb 2013 | B2 |
8377138 | Reo et al. | Feb 2013 | B2 |
8382838 | Baumgartner et al. | Feb 2013 | B2 |
8398511 | Sandusky | Mar 2013 | B2 |
8403987 | Reo et al. | Mar 2013 | B2 |
8419839 | Shimatani | Apr 2013 | B2 |
8444694 | Collins et al. | May 2013 | B2 |
8449660 | Shimatani et al. | May 2013 | B2 |
8454612 | Lambrecht et al. | Jun 2013 | B2 |
8460383 | Wirtel, III et al. | Jun 2013 | B2 |
8480718 | Protopsaltis et al. | Jul 2013 | B2 |
8540772 | Osman | Sep 2013 | B2 |
8551172 | Park | Oct 2013 | B2 |
8562634 | Middleton | Oct 2013 | B2 |
8603171 | McClellan, III et al. | Dec 2013 | B2 |
8632592 | Barrall | Jan 2014 | B2 |
8636803 | Hibri et al. | Jan 2014 | B2 |
8663328 | Justis et al. | Mar 2014 | B2 |
8690919 | Lange et al. | Apr 2014 | B2 |
8727920 | Sandusky | May 2014 | B2 |
8734459 | Alobaid | May 2014 | B1 |
8747475 | Kuslich | Jun 2014 | B2 |
8808381 | Kim et al. | Aug 2014 | B2 |
8888850 | Linares | Nov 2014 | B2 |
8894563 | Connors et al. | Nov 2014 | B2 |
8945223 | Trieu | Feb 2015 | B2 |
8979931 | Stad et al. | Mar 2015 | B2 |
9486323 | Hibri et al. | Nov 2016 | B1 |
20020026244 | Trieu | Feb 2002 | A1 |
20020068975 | Teitelbaum et al. | Jun 2002 | A1 |
20020147497 | Belef et al. | Oct 2002 | A1 |
20020151979 | Lambrecht et al. | Oct 2002 | A1 |
20020198588 | Armstrong et al. | Dec 2002 | A1 |
20030028251 | Mathews | Feb 2003 | A1 |
20030040772 | Hyodoh et al. | Feb 2003 | A1 |
20030114917 | Holloway et al. | Jun 2003 | A1 |
20030153976 | Cauthen et al. | Aug 2003 | A1 |
20030199979 | McGuckin, Jr. | Oct 2003 | A1 |
20040092948 | Stevens et al. | May 2004 | A1 |
20040106999 | Mathews | Jun 2004 | A1 |
20040186471 | Trieu | Sep 2004 | A1 |
20040220672 | Shadduck | Nov 2004 | A1 |
20040230309 | DiMauro et al. | Nov 2004 | A1 |
20050004578 | Lambrecht et al. | Jan 2005 | A1 |
20050015150 | Lee | Jan 2005 | A1 |
20050055099 | Ku | Mar 2005 | A1 |
20050065609 | Wardlaw | Mar 2005 | A1 |
20050090901 | Studer | Apr 2005 | A1 |
20050113919 | Cragg et al. | May 2005 | A1 |
20050119752 | Williams et al. | Jun 2005 | A1 |
20050119852 | Iguchi et al. | Jun 2005 | A1 |
20050137675 | Dubson et al. | Jun 2005 | A1 |
20050197702 | Coppes et al. | Sep 2005 | A1 |
20050251259 | Suddaby | Nov 2005 | A1 |
20050278029 | Trieu | Dec 2005 | A1 |
20060047296 | Embry et al. | Mar 2006 | A1 |
20060149380 | Lotz | Jul 2006 | A1 |
20060247780 | Bert | Nov 2006 | A1 |
20060253132 | Evans et al. | Nov 2006 | A1 |
20060265077 | Zwirkoski | Nov 2006 | A1 |
20060293749 | Hudgins et al. | Dec 2006 | A1 |
20070021835 | Edidin | Jan 2007 | A1 |
20070060924 | Choi | Mar 2007 | A1 |
20070073402 | Vresilovic et al. | Mar 2007 | A1 |
20070093906 | Hudgins et al. | Apr 2007 | A1 |
20070135921 | Park | Jun 2007 | A1 |
20070150061 | Trieu | Jun 2007 | A1 |
20070162135 | Segal et al. | Jul 2007 | A1 |
20070162136 | O'Neil et al. | Jul 2007 | A1 |
20070168031 | Hudgins et al. | Jul 2007 | A1 |
20070168042 | Hudgins et al. | Jul 2007 | A1 |
20070173935 | O'Neil et al. | Jul 2007 | A1 |
20070173940 | Hestad et al. | Jul 2007 | A1 |
20070200271 | Dave | Aug 2007 | A1 |
20070213732 | Khanna et al. | Sep 2007 | A1 |
20070255285 | Trieu | Nov 2007 | A1 |
20070255406 | Trieu | Nov 2007 | A1 |
20070265077 | Tom et al. | Nov 2007 | A1 |
20070270953 | Trieu | Nov 2007 | A1 |
20070288095 | Wirtel et al. | Dec 2007 | A1 |
20080046082 | Lee | Feb 2008 | A1 |
20080058932 | Trieu et al. | Mar 2008 | A1 |
20080119943 | Armstrong et al. | May 2008 | A1 |
20080132934 | Reiley et al. | Jun 2008 | A1 |
20080154367 | Justis et al. | Jun 2008 | A1 |
20080154368 | Justis et al. | Jun 2008 | A1 |
20080154373 | Protopsaltis et al. | Jun 2008 | A1 |
20080195210 | Milijasevic et al. | Aug 2008 | A1 |
20080288073 | Renganath et al. | Nov 2008 | A1 |
20080288074 | O'Neil et al. | Nov 2008 | A1 |
20090012618 | Ahrens et al. | Jan 2009 | A1 |
20090030399 | Raiszadeh et al. | Jan 2009 | A1 |
20090076609 | Stewart | Mar 2009 | A1 |
20090076610 | Afzal | Mar 2009 | A1 |
20090082870 | Osman | Mar 2009 | A1 |
20090105823 | Williams et al. | Apr 2009 | A1 |
20090112221 | Burke et al. | Apr 2009 | A1 |
20090112323 | Hestad et al. | Apr 2009 | A1 |
20090118833 | Hudgins et al. | May 2009 | A1 |
20090138053 | Assell et al. | May 2009 | A1 |
20090163994 | Quigley et al. | Jun 2009 | A1 |
20090222093 | Liu et al. | Sep 2009 | A1 |
20090240341 | Diwan et al. | Sep 2009 | A1 |
20090299476 | Diwan et al. | Dec 2009 | A1 |
20100030216 | Arcenio | Feb 2010 | A1 |
20100145462 | Ainsworth et al. | Jun 2010 | A1 |
20100191335 | Root et al. | Jul 2010 | A1 |
20100193999 | Anneaux et al. | Aug 2010 | A1 |
20100256619 | Teitelbaum et al. | Oct 2010 | A1 |
20100256766 | Hibri et al. | Oct 2010 | A1 |
20100292798 | Maestretti | Nov 2010 | A1 |
20110022089 | Assell et al. | Jan 2011 | A1 |
20110093076 | Reo et al. | Apr 2011 | A1 |
20110125158 | Diwan et al. | May 2011 | A1 |
20110190753 | Forrest | Aug 2011 | A1 |
20110196499 | Boucher et al. | Aug 2011 | A1 |
20110264224 | Ferree | Oct 2011 | A1 |
20110282418 | Saunders et al. | Nov 2011 | A1 |
20110319996 | Barrall | Dec 2011 | A1 |
20120089227 | Jarzem | Apr 2012 | A1 |
20120089229 | Thramann | Apr 2012 | A1 |
20120165941 | Rabiner et al. | Jun 2012 | A1 |
20120277862 | Tornier et al. | Nov 2012 | A1 |
20120310352 | DiMauro et al. | Dec 2012 | A1 |
20120316648 | Lambrecht et al. | Dec 2012 | A1 |
20130004586 | Vachon et al. | Jan 2013 | A1 |
20130103155 | Tornier et al. | Apr 2013 | A1 |
20130131806 | Carpetner | May 2013 | A1 |
20130297026 | de Villiers et al. | Nov 2013 | A1 |
20130304212 | VonGunten | Nov 2013 | A1 |
20140052250 | Wirtel et al. | Feb 2014 | A1 |
20140094914 | Hibri et al. | Apr 2014 | A1 |
20140276832 | Hibri et al. | Sep 2014 | A1 |
20140277467 | Hibri et al. | Sep 2014 | A1 |
20140288656 | Kuslich | Sep 2014 | A1 |
20150057752 | Hibri et al. | Feb 2015 | A1 |
20160120653 | Hibri et al. | May 2016 | A1 |
20160120654 | Hibri et al. | May 2016 | A1 |
20170056195 | Lutz et al. | Mar 2017 | A1 |
Number | Date | Country |
---|---|---|
2468908 | Jun 2003 | CA |
101076302 | Nov 2007 | CN |
101448471 | Jun 2009 | CN |
101557779 | Oct 2009 | CN |
103099689 | May 2013 | CN |
2005511143 | Apr 2005 | JP |
2012513243 | Jun 2012 | JP |
20120040309 | Apr 2012 | KR |
WO 2001097721 | Dec 2001 | WO |
WO 2003047472 | Jun 2003 | WO |
WO 2006060482 | Dec 2005 | WO |
WO 2006025815 | Mar 2006 | WO |
WO 2006130796 | Dec 2006 | WO |
WO 2007087404 | Aug 2007 | WO |
WO 2014158762 | Oct 2014 | WO |
WO 2016073587 | May 2016 | WO |
Entry |
---|
International Search Report and Written Opinion from the International Searching Authority issued in corresponding International application No. PCT/US2019/049548 dated May 7, 2021. |
Office Action from the United States Patent and Trademark Office issued in corresponding patent U.S. Appl. No. 15/958,715 dated Sep. 9, 2020. |
Notice of Reasons for Rejection from the Japanese Patent Office issued in corresponding patent Application No. 2018-530671 dated Sep. 2, 2020. |
Search Report from China National Intellectual Property Administration issued in corresponding Patent Application No. 201680058105X dated Apr. 23, 2020. |
The First Office Action from the China National Intellectual Property Administration issued in corresponding Patent Application No. 201680058105X dated Apr. 30, 2020. |
Examination Report No. 1 from IP Australia issued in corresponding Patent Application No. 2016315964 dated May 23, 2020. |
First Examination Report from the Indian Patent Office issued in corresponding Application No. 8509/DELNP/2015 dated Oct. 28, 2020. |
Office Action Issued in Corresponding Brazilian Patent Application No. BR112015023003-2, dated Jan. 22, 2020. |
Office Action issued in Corresponding Canadian Application No. 2,906,340, dated Feb. 27, 2020. |
Supplementary European Search Report issued in European Application No. 15857214.9, dated Oct. 10, 2017. |
Notice of Preliminary Rejection from the Korean Intellectual Property Office in corresponding application No. 10-2015-7028728 dated Sep. 28, 2020. |
International Search Report and Written Opinion for PCT/US2015/058976 dated Jan. 25, 2016. |
Office Action issued in Chinese Patent Application No. 201580066464.5, dated Aug. 2, 2018. Received Aug. 22, 2018. |
Non-Final Office Action issued by the United States Patent and Trademark Office in related U.S. Appl. No. 16/560,684 dated Apr. 5, 2021. |
Birkenmaier et al., “Minimally Invasive Endoscopic Spinal Surgery”, www.pineuniverse.com/displayarticle.pho/article2016.html. |
Examination Report No. 1 from IP Australia issued in corresponding Patent Application No. 2015343171 dated Aug. 19, 2019. |
International Search Report and Written Opinion for PCT/US2015/059011, dated Feb. 15, 2016. |
International Search Report and Written Opinion issued in PCT Application No. PCT/US2016/049816, dated Dec. 8, 2016. |
International Search Report dated Jun. 17, 2014 for International Application No. PCT/US2014/019911, filed Mar. 3, 2014. |
International Search Report dated Jun. 19, 2014 for International Application No. PCT/US2014/019887. |
International Search Report dated Jun. 25, 2014 for International Application No. PCT/US2014/019957, filed Mar. 3, 2014. |
Sharma et al., “Manufacturing of Doubly Curved Tubular Composite Structure: Mapping and Weave Modification,” Thermoplastic Composite Materials, 15:209-225 (May 2002). |
Supplementary European Search Report issued in European Patent Application No. 16842957.9, dated Jul. 26, 2018. |
Viscocliosi et al., “Beyond Total Disc: The Future of Spine Surgery,” Spine Non-Fusion, Musculoskeletal Investment Research, pp. 1-289, (May 2004). |
Wu et al., “The direct effect of graft compliance mismatch per se on development of host arterial intimal hyperplasia at the anastomotic interface,” Annals of Vascular Surgery, 7(2):156-168 (Mar. 1993). |
Office Action issued in Corresponding Canadian Application No. 2,966,748, dated Dec. 3, 2021. |
Number | Date | Country | |
---|---|---|---|
20190247196 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
62074925 | Nov 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14932242 | Nov 2015 | US |
Child | 16396042 | US |